Although it can be argued that the risk improvement was borderline significant, it remains to be assessed if the evaluation of several different inflammation-related biomarkers leads to a sufficient improvement in type 2 diabetes risk estimation to be cost-effective and easily implemented in clinical practice.
← all excerpts
Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.
2
—
—
The sentences
In this study, a highly significant positive association was found between hs-CRP levels and incident type 2 diabetes, but this association was no longer significant after multivariate adjustment, a finding also reported previously [5] , [37] .